Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 1
1989 1
1990 1
1992 4
1993 3
1994 3
1995 1
1996 2
1997 2
1998 5
1999 8
2000 5
2001 4
2002 9
2003 8
2004 6
2005 13
2006 13
2007 13
2008 13
2009 16
2010 14
2011 14
2012 18
2013 28
2014 32
2015 30
2016 28
2017 26
2018 26
2019 28
2020 44
2021 53
2022 42
2023 46
2024 47
2025 25

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

570 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, safety, and immunogenicity of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over three respiratory syncytial virus seasons (AReSVi-006): a multicentre, randomised, observer-blinded, placebo-controlled, phase 3 trial.
Ison MG, Papi A, Athan E, Feldman RG, Langley JM, Lee DG, Leroux-Roels I, Martinon-Torres F, Schwarz TF, van Zyl-Smit RN, Cuadripani S, Deraedt Q, Dezutter N, Gerard C, Fissette L, Xavier S, David MP, Olivier A, Van der Wielen M, Descamps D; AReSVi-006 study group. Ison MG, et al. Among authors: papi a. Lancet Respir Med. 2025 Apr 11:S2213-2600(25)00048-7. doi: 10.1016/S2213-2600(25)00048-7. Online ahead of print. Lancet Respir Med. 2025. PMID: 40245915
Reply to Correspondence: The Bronchodilator and Anti-Inflammatory Effect of Long-Acting Muscarinic Antagonists in Asthma: An EAACI Position Paper.
Agache I, Adcock IM, Akdis CA, Akdis M, Bentabol-Ramos G, van den Berge M, Boccabella C, Canonica GW, Caruso C, Couto M, Davila I, Drummond D, Fonseca J, Gherasim A, Del Giacco S, Jackson DJ, Jutel M, Licari A, Loukides S, Moreira A, Mukherjee M, Ojanguren I, Palomares O, Papi A, Perez de Llano L, Price OJ, Rukhazde M, Shamji MH, Shaw D, Sanchez-Garcia S, Testera-Montes A, Torres MJ, Eguiluz-Gracia I. Agache I, et al. Among authors: papi a. Allergy. 2025 Apr 11. doi: 10.1111/all.16557. Online ahead of print. Allergy. 2025. PMID: 40214719 No abstract available.
Personalised therapeutic approaches for asthma.
Agache I, Adcock IM, Baraldi F, Chung KF, Eguiluz-Gracia I, Johnston SL, Jutel M, Nair P, Papi A, Porsbjerg C, Usmani OS, Meyers DA, Zemelka-Wiacek M, Bleecker ER. Agache I, et al. Among authors: papi a. J Allergy Clin Immunol. 2025 Apr 7:S0091-6749(25)00375-6. doi: 10.1016/j.jaci.2025.03.025. Online ahead of print. J Allergy Clin Immunol. 2025. PMID: 40203996 Review.
Climate Change & COPD: A GOLD Science Committee Review.
Halpin DMG, Balmes J, Han MK, Papi A, Martinez FJ, Montes de Oca M, Ozoh OB, Salvi S, Sin DD, Zheng J, Agusti A, Vogelmeier C. Halpin DMG, et al. Among authors: papi a. Am J Respir Crit Care Med. 2025 Mar 12. doi: 10.1164/rccm.202410-2058PP. Online ahead of print. Am J Respir Crit Care Med. 2025. PMID: 40072246 No abstract available.
Raising the bar in respiratory care by EUFOREA: report of the European Union Parliament Symposium, April 2024.
Hellings PW, Conti DM, Bertels X, Backer V, Brusselle G, De Corso E, Fokkens WJ, Fox AT, Gevaert P, Lau S, Liva G, Palkonen S, Papi A, Scheire S, Schmid-Grendelmeier P, Shire CME, Smith P, Teeling MTA, Yorgancioglu A, Scadding GK. Hellings PW, et al. Among authors: papi a. Front Allergy. 2025 Feb 24;6:1540499. doi: 10.3389/falgy.2025.1540499. eCollection 2025. Front Allergy. 2025. PMID: 40065834 Free PMC article.
Dupilumab reduces acute exacerbations and improves lung function in patients with COPD with type 2 inflammation irrespective of body mass index, airflow obstruction, dyspnea, and exercise capacity index scores.
Vogelmeier CF, Rabe KF, Bhatt SP, Hanania NA, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Maloney J, Dakin P, Lu X, Bauer D, Bansal A, Robinson LB, Abdulai RM. Vogelmeier CF, et al. Among authors: papi a. Respir Med. 2025 May;241:108015. doi: 10.1016/j.rmed.2025.108015. Epub 2025 Feb 28. Respir Med. 2025. PMID: 40024335 Free article. Clinical Trial.
Hydrogenated Amorphous Silicon Charge-Selective Contact Devices on a Polyimide Flexible Substrate for Dosimetry and Beam Flux Measurements.
Menichelli M, Aziz S, Bashiri A, Bizzarri M, Buti C, Calcagnile L, Calvo D, Caprai M, Caputo D, Caricato AP, Catalano R, Cazzanelli M, Cirio R, Cirrone GAP, Cittadini F, Croci T, Cuttone G, de Cesare G, De Remigis P, Dunand S, Fabi M, Frontini L, Grimani C, Guarrera M, Hasnaoui H, Ionica M, Kanxheri K, Large M, Lenta F, Liberali V, Lovecchio N, Martino M, Maruccio G, Mazza G, Monteduro AG, Morozzi A, Nascetti A, Pallotta S, Papi A, Passeri D, Pedio M, Petasecca M, Petringa G, Peverini F, Placidi P, Polo M, Quaranta A, Quarta G, Rizzato S, Sabbatini F, Servoli L, Stabile A, Talamonti C, Thomet JE, Tosti L, Mora MSV, Villani M, Wheadon RJ, Wyrsch N, Zema N. Menichelli M, et al. Among authors: papi a. Sensors (Basel). 2025 Feb 19;25(4):1263. doi: 10.3390/s25041263. Sensors (Basel). 2025. PMID: 40006492 Free PMC article.
570 results